The Magazine for Sleep Professionals
Monday, May 4, 2026
Acquisitions | Awards | Events | News | Partnerships
Eli Lilly and Company and Centessa Pharmaceuticals plc, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, announced a definitive agreement for Lilly to acquire Centessa. Centessa is advancing a pipeline of orexin receptor 2 (OX2R) agonists designed to […]
LivaNova PLC announced the U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) for the aura6000™ System for the treatment of adult patients with moderate to severe Obstructive Sleep Apnea (OSA). The System utilizes proximal hypoglossal nerve stimulation (p-HGNS), a differentiated neurostimulation modality, to treat OSA in patients with […]
Sunrise Group announced results from the SUNSAS clinical study, now published in The Lancet Regional Health – Europe, a leading international medical journal. Supported by the French Ministry of Health through the Forfait Innovation program, this study is the largest randomized controlled trial to date evaluating an at-home diagnostic pathway for obstructive […]
Wearable devices and digital apps that are available to consumers are emerging as potential tools in neurological care. These include smart watches and fitness trackers to monitor heart rate, physical activity, sleep and other health factors. To provide neurologists with guidance on the use, limitations and evidence on non-U.S. Food […]
Update: This resolution was passed by the California State Assembly. “Today marks a historic moment for sleep medicine and public health. By formally recognizing Sleep Apnea Awareness Month, California has acknowledged what millions of families already experience every night. Sleep apnea is one of the largest and most serious undiagnosed […]
Panthera Dental is proud to announce Dr. Chidsanu Changsiripun (PI), D.D.S., M.Sc., Ph.D., from Chulalongkorn University, Thailand, as the recipient of the 2025 Panthera Sleep Research Grant. Dr. Changsiripun’s research proposal, Deep Learning-Assisted vs. Conventional Subjective Titration in MAD Therapy for OSA, was selected through a rigorous anonymous peer-review process […]
British Columbia has adopted permanent year-round daylight saving time (DST) to improve people’s overall health, reduce disruptions for families, simplify scheduling, and provide an extra hour of evening light during the winter months. The transition to one year-round time zone began on Sunday, March 8, 2026, when clocks moved ahead […]
Bleep LLC, maker of the Eclipse™ mask-less CPAP solution, announced technologist and electronics industry veteran Tom Beckley has joined the Company’s Board of Directors. “As a successful technology entrepreneur with extensive knowledge of AI, software and advanced electro-mechanical systems, I’m very pleased Tom has joined Bleep’s Board of Directors,” said […]
Nexalin Technology, Inc. announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical […]
